Flu

Pharmacists play a vital role in providing education and administering influenza, COVID-19, and RSV Vaccines

Experts answer questions on influenza vaccines.

Community pharmacies and organizations can collaborate to tailor strategies and interventions and address the challenges and specific needs of the community.

By educating their patients on the provisions of the Inflation Reduction Act, pharmacists can have an even greater impact by increasing vaccine uptake in historically underserved groups.

Compared with COVID-19 vaccination alone, recent study findings show health care workers who received both a COVID-19 booster and influenza vaccinations did not have lower immune response or more frequent adverse events.

Evidence-based programs and policies to improve vaccine uptake are necessary for both caregivers and the general public because influenza vaccine coverage remains low for both groups.

Senate Bill 219 will also allow pharmacists to independently administer influenza and COVID-19 tests waived by the clinical laboratory improvement amendments.

While monitoring influenza virus resistance as it develops, researchers are prioritizing further investigations to decrease the risk of resistant strains.

Having 2 drug classes available for influenza is significant, but it is important to investigate other treatments prior to the pandemic, a new study indicates.

With new vaccines expected for both SARS-CoV-2 and influenza, educate patients on the ongoing need for immunizations

With back-to-school season already over and the fall rapidly approaching, health systems are bracing for another season of influenza, COVID-19, and respiratory syncytial virus.

Despite study findings showing that 1 in 5 patients hospitalized for COVID-19 developed persistent high blood pressure, many had underlying risk factors.

This technique may be applied to transdermal applications, such as shot-free vaccines.

Experts discuss the social determinants that can affect the rates of flu immunizations and strategies to boost immunization rates.

Chad Worz, PharmD, BCGP, FASCP, and the panel review the NUDGE-FLU Trial and discuss the study design, outcomes, and how similar nudges can be incorporated into practice.

An expert panel reviews the signs of vaccine hesitancy and how pharmacists can address patient concerns.

Pharmacies brace for a double wave of DIR fees while paddling against profit struggles. Enter Pharmacy AI: a transformative vehicle to navigate stormy waters, enhance efficiency, and prioritize patient care.

Gretchen Garofoli, PharmD, an associate professor at the West Virginia School of Pharmacy, discusses the current recommendations for COVID-19, respiratory syncytial virus (RSV), and influenza vaccines and vaccine hesitancy.

A bit of preparation can set children up for success and reduce the stress of this busy time.

The approved assay can differentiate between infection of COVID-19, influenza, or respiratory syncytial virus, minimizing the need for multiple tests or physician visits.

Community-based pharmacy services are reaching new heights as pharmacists and pharmacy technicians are able to have a larger impact on patient care than ever before.

With the end of the national public health emergency for COVID-19 in May 2023, what can be expected as we look ahead to the 2023-2024 influenza season and beyond?

Every pharmacist can make a difference in patients’ lives by taking the time to understand and fulfill the community’s social and cultural needs.

The effectiveness of influenza vaccines varies each season and is determined by the circulating influenza virus subtype(s) and the extent to which there is an antigenic match in the vaccines to the circulating virus subtypes.

Expanding pharmacist–patient care services to include vaccine promotion and administration within ambulatory clinics is an example of the expanding role of pharmacists and their contribution to primary care practice.